Back to results
US 2013/0274177 A1Published application
Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
OwnerPawan SAHARANinventor
Life of this patent
Estimating the term…
Abstract
The present Invention relates to nanopeptides isolated from mammalian colostrums with vaccine like antiviral and immunodulator activity via building body's own immune system and attachment inhibition on the cell surface receptors.
Claims6
1-30. (canceled)
A method for treating immune related disorders, including autoimmune disorders, comprising:
- administering to a patient in need thereof a therapeutically effective amount of formulation comprising:
- between 0.1% to 1% by volume of peptides isolated from mammalian colostrum having sequences as recited in SEQ ID 1-8 wherein the peptides function to modulate cell immunity and provide attachment inhibition for foreign antigen/viruses on cell surface receptors.
Dependencies are inferred from the claim text.